Article
Synergistic effects of novel penicillin-binding protein 1A amino acid substitutions contribute to high-level amoxicillin resistance of Helicobacter pylori.
mSphere - 28 Aug 2024
Cimuanga-Mukanya Alain, Tshibangu-Kabamba Evariste, Kisoko Patrick de Jesus Ngoma, Fauzia Kartika Afrida, Tshibangu Fabien Mbaya, Wola Antoine Tshimpi, Kashala Pascal Tshiamala, Ngoyi Dieudonné Mumba, Ahuka-Mundeke Steve, Revathi Gunturu, Disashi-Tumba Ghislain, Kido Yasutoshi, Matsumoto Takashi, Akada Junko, Yamaoka Yoshio
Abstract excerpt
The growing resistance to amoxicillin (AMX)-one of the main antibiotics used in Helicobacter pylori eradication therapy-is an increasing health concern. Several mutations of penicillin-binding protein 1A (PBP1A) are suspected of causing AMX resistance; however, only a limited set of these mutations have been experimentally explored. This study aimed to investigate four PBP1A mutations (i.e., T558S, N562H, T593A,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
